"Navigating the Modern News Zoo so you don't have to."
Saturday, July 19, 2025
AI can accelerate search for more effective Alzheimer's medicines by streamlining clinical trials
Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer's disease drug. They found that the drug slowed cognitive decline by 46% in a group of patients with early-stage, slow-progressing mild cognitive impairment—a condition that can progress to Alzheimer's.
Samsung's New Flip 7: Is It The Best Flip Ever?
- ‘You’re stupid!’ GB News migrant row descends into shouting match as guest loses it - Isaiah Amos
- Low US Household Leverage Bodes Well For The Economy - Financial Samurai
- Man’s ghastly festering ulcer stumps doctors—until they cut out a wedge of flesh - Beth Mole
- Harmonised Solutions Connect Exporters and Importers in Volatile Markets - GFMag.com Admin
- Claude Code revenue jumps 5.5x as Anthropic launches analytics dashboard - Michael Nuñez
- Eddington Review: Ari Aster's Black Mirror - Drew Dietsch
Elon And Trump Break Up - What Happens Now
- Michael Madsen's Last Great Spotlight Shows We Undervalued His Talent - Drew Dietsch
- What Happens When Non-Small Cell Lung Cancer Becomes Metastatic? - Carrie Madormo, RN, MPH
- VeriSilicon Launches Advanced VC9800 Series for Next-Gen Data Centers - Sean George
- Moderna says mRNA flu vaccine sailed through trial, beating standard shot - Beth Mole
- Belkin shows tech firms getting too comfortable with bricking customers’ stuff - Scharon Harding
- Feel-Good Friday: Dad Who Gave Up His Truck to Support the Family Gets a New One for His 65th Birthday
